Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,551
Total Claims
$1.9M
Drug Cost
569
Beneficiaries
$3,288
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
-94%
Opioid rate vs peers
0.2% vs 2.5% avg
+192%
Cost per patient vs peers
$3,288 vs $1,128 avg
+112%
Brand preference vs peers
17.8% vs 8.4% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.2%
Opioid Rate
36
Opioid Claims
$1,065
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 4,000 claims · $1.2M
Generic: 18,494 claims · $625K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 806 | $215K |
| Valbenazine Tosylate | 35 | $165K |
| Imatinib Mesylate | 13 | $77K |
| Rivaroxaban | 279 | $74K |
| Insulin Glargine,hum.Rec.Anlog | 75 | $42K |
| Linagliptin | 150 | $39K |
| Linaclotide | 72 | $39K |
| Sitagliptin Phosphate | 142 | $38K |
| Rifaximin | 30 | $36K |
| Pimavanserin Tartrate | 12 | $27K |
| Insulin Glargine,hum.Rec.Anlog | 102 | $23K |
| Lurasidone Hcl | 34 | $21K |
| Mirtazapine | 646 | $20K |
| Dextromethorphan Hbr/Quinidine | 28 | $20K |
| Empagliflozin | 70 | $20K |
Prescribing Profile
Patient Profile
80
Avg Age
67%
Female
2.71
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data